cmp-001
Showing 1 - 9 of 9
Melanoma, Lymph Node Cancer Trial in Pittsburgh (CMP-001, Nivolumab)
Active, not recruiting
- Melanoma
- Lymph Node Cancer
- CMP-001
- Nivolumab
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Mar 15, 2022
Colorectal Tumors Malignant, Liver Metastases Trial in Ramat Gan (Liver radiation therapy, Nivolumab Injection [Opdivo],
Active, not recruiting
- Colorectal Neoplasms Malignant
- Liver Metastases
- Liver radiation therapy
- +3 more
-
Ramat Gan, IsraelSheba Medical Center
May 20, 2022
Merkel Cell Carcinoma, Cutaneous Squamous Cell Carcinoma, Metastatic Cancer Trial in United States (CMP-001, cemiplimab-rwlc)
Recruiting
- Merkel Cell Carcinoma
- +4 more
- CMP-001
- cemiplimab-rwlc
-
Jacksonville, Florida
- +6 more
Feb 24, 2022
Squamous Cell Carcinoma of Head and Neck Trial in United States (CMP-001, Pembrolizumab)
Active, not recruiting
- Squamous Cell Carcinoma of Head and Neck
- CMP-001
- Pembrolizumab
-
Little Rock, Arkansas
- +18 more
Aug 1, 2022
Triple Negative Breast Cancer Trial in Lausanne (stereotactic body radiotherapy, CMP-001)
Recruiting
- Triple Negative Breast Cancer
- stereotactic body radiotherapy
- CMP-001
-
Lausanne, Vaud, SwitzerlandCHUV Oncology Department
Jul 6, 2021
